Literature DB >> 24368861

Humidification performance of two high-flow nasal cannula devices: a bench study.

Yusuke Chikata, Masayo Izawa, Nao Okuda, Taiga Itagaki, Emiko Nakataki, Mutsuo Onodera, Hideaki Imanaka, Masaji Nishimura.   

Abstract

INTRODUCTION: Delivering heated and humidified medical gas at 20-60 L/min, high-flow nasal cannula (HFNC) creates low levels of PEEP and ameliorates respiratory mechanics. It has become a common therapy for patients with respiratory failure. However, independent measurement of heat and humidity during HFNC and comparison of HFNC devices are lacking.
METHODS: We evaluated 2 HFNC (Airvo 2 and Optiflow system) devices. Each HFNC was connected to simulated external nares using the manufacturer's standard circuit. The Airvo 2 outlet-chamber temperature was set at 37°C. The Optiflow system incorporated an O2/air blender and a heated humidifier, which was set at 40°C/3. For both systems, HFNC flow was tested at 20, 40, and 50 L/min. Simulating spontaneous breathing using a mechanical ventilator and TTL test lung, we tested tidal volumes (VT) of 300, 500, and 700 mL, and breathing frequencies of 10 and 20 breaths/min. The TTL was connected to the simulated external nares with a standard ventilator circuit. To prevent condensation, the circuit was placed in an incubator maintained at 37°C. Small, medium, and large nasal prongs were tested. Absolute humidity (AH) of inspired gas was measured at the simulated external nares.
RESULTS: At 20, 40, and 50 L/min of flow, respective AH values for the Airvo 2 were 35.3 ± 2.0, 37.1 ± 2.2, and 37.6 ± 2.1 mg/L, and for the Optiflow system, 33.1 ± 1.5, 35.9 ± 1.7, and 36.2 ± 1.8 mg/L. AH was lower at 20 L/min of HFNC flow than at 40 and 50 L/min (P < .01). While AH remained constant at 40 and 50 L/min, at 20 L/min of HFNC flow, AH decreased as VT increased for both devices.
CONCLUSIONS: During bench use of HFNC, AH increased with increasing HFNC flow. When the inspiratory flow of spontaneous breathing exceeded the HFNC flow, AH was influenced by VT. At all experimental settings, AH remained > 30 mg/L.

Entities:  

Mesh:

Year:  2014        PMID: 24368861     DOI: 10.4187/respcare.02932

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  12 in total

1.  Noninvasive respiratory support for acute respiratory failure-high flow nasal cannula oxygen or non-invasive ventilation?

Authors:  Gerard F Curley; John G Laffy; Haibo Zhang; Arthur S Slutsky
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

Review 2.  High-flow nasal cannula oxygen therapy in adults.

Authors:  Masaji Nishimura
Journal:  J Intensive Care       Date:  2015-03-31

Review 3.  High-flow nasal cannula: recommendations for daily practice in pediatrics.

Authors:  Christophe Milési; Mathilde Boubal; Aurélien Jacquot; Julien Baleine; Sabine Durand; Marti Pons Odena; Gilles Cambonie
Journal:  Ann Intensive Care       Date:  2014-09-30       Impact factor: 6.925

4.  High-flow nasal oxygen vs. standard oxygen therapy in immunocompromised patients with acute respiratory failure: study protocol for a randomized controlled trial.

Authors:  Elie Azoulay; Virginie Lemiale; Djamel Mokart; Saad Nseir; Laurent Argaud; Frédéric Pène; Loay Kontar; Fabrice Bruneel; Kada Klouche; François Barbier; Jean Reignier; Anabelle Stoclin; Guillaume Louis; Jean-Michel Constantin; Julien Mayaux; Florent Wallet; Achille Kouatchet; Vincent Peigne; Pierre Perez; Christophe Girault; Samir Jaber; Johanna Oziel; Martine Nyunga; Nicolas Terzi; Lila Bouadma; Christine Lebert; Alexandre Lautrette; Naike Bigé; Jean-Herlé Raphalen; Laurent Papazian; Antoine Rabbat; Michael Darmon; Sylvie Chevret; Alexandre Demoule
Journal:  Trials       Date:  2018-03-05       Impact factor: 2.279

Review 5.  Physiological Effects of High-Flow Nasal Cannula Therapy and Its Use in Acute Cardiogenic Pulmonary Edema.

Authors:  Prakash Adhikari; Sanket Bhattarai; Ashish Gupta; Eiman Ali; Moeez Ali; Mohamed Riad; Jihan A Mostafa
Journal:  Cureus       Date:  2021-02-16

Review 6.  The Mechanisms of Benefit of High-Flow Nasal Therapy in Stable COPD.

Authors:  Massa Zantah; Aloknath Pandya; Michael R Jacobs; Gerard J Criner
Journal:  J Clin Med       Date:  2020-11-26       Impact factor: 4.241

7.  The effects of a 2-h trial of high-flow oxygen by nasal cannula versus Venturi mask in immunocompromised patients with hypoxemic acute respiratory failure: a multicenter randomized trial.

Authors:  Virginie Lemiale; Djamel Mokart; Julien Mayaux; Jérôme Lambert; Antoine Rabbat; Alexandre Demoule; Elie Azoulay
Journal:  Crit Care       Date:  2015-11-02       Impact factor: 9.097

Review 8.  High-flow nasal cannula therapy for adult patients.

Authors:  Jian Zhang; Ling Lin; Konghan Pan; Jiancang Zhou; Xiaoyin Huang
Journal:  J Int Med Res       Date:  2016-10-03       Impact factor: 1.671

Review 9.  High-flow nasal cannula oxygen therapy as an emerging option for respiratory failure: the present and the future.

Authors:  Lucia Spicuzza; Matteo Schisano
Journal:  Ther Adv Chronic Dis       Date:  2020-05-13       Impact factor: 5.091

10.  High Flow Oxygen Therapy at Two Initial Flow Settings versus Conventional Oxygen Therapy in Cardiac Surgery Patients with Postextubation Hypoxemia: A Single-Center, Unblinded, Randomized, Controlled Trial.

Authors:  Stavros Theologou; Eleni Ischaki; Spyros G Zakynthinos; Christos Charitos; Nektaria Michopanou; Stratos Patsatzis; Spyros D Mentzelopoulos
Journal:  J Clin Med       Date:  2021-05-12       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.